EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
Solvay pharma expands its product portfolio, by launching alfa normix (rifaximin) for the treatment of the gastroenteric infections. Alfa normix is a non-systemic broad-spectrum antibiotic to treat acute gastroenteric infections and is prescribed for the travelers suffering from diarrhea, the overgr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Paediatrician Publishers, LLC
2008-05-01
|
| Series: | Pediatričeskaâ Farmakologiâ |
| Online Access: | https://www.pedpharma.ru/jour/article/view/868 |